NOVTNovanta Inc.

Ticker: NOVT | Filing: 10-Q | Filed: November 9, 2026 | Current Price: $122.68 | Today's Change: -15.96%

---

What Happened

Novanta Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the third quarter of fiscal year 2026. According to the structured financial data extracted directly from the filing's official XBRL data, the company reported revenue of $722.3 million for Q3 FY2026, with operating income of $69.2 million and net income of $36.4 million. Earnings per share came in at $1.01 on both a basic and diluted basis.

Why It Matters

The market's reaction is unambiguous: shares of NOVT fell nearly 16% on the day of this report, suggesting the Q3 results landed well below investor expectations. While the absolute figures — $722.3 million in revenue and $36.4 million in net income — represent a significant business in scale, the sharp stock decline signals that the market was anticipating a materially stronger performance. For investors, this is a critical inflection point: the near-term picture for Novanta has shifted, with valuation assumptions likely being reset by the market in real time. StockWatch's initiating coverage, published September 22, 2026, had established a framework for evaluating NOVT's prospects; this quarter's outcome puts that backdrop under fresh scrutiny.

Analysis

The magnitude of today's selloff — approaching 16% — is notable and suggests that either revenue, profitability, or forward guidance (or some combination thereof) fell short of what the market had priced in. The gap between the $155.00 price target embedded in StockWatch's prior coverage and the current price of $122.68 has widened sharply, underscoring how materially this quarter has reset expectations.

A few key items to watch going forward:

• Operating margin: Operating income of $69.2 million on revenue of $722.3 million implies an operating margin of roughly 9.6%. For a precision motion and sensing technology company like Novanta, investors will be scrutinizing whether this margin reflects a temporary headwind or a structural step-down.
• Revenue trajectory: The Q3 FY2026 revenue figure of $722.3 million is provided in the XBRL data as a nine-month or single-quarter figure — investors should consult the full filing to confirm the precise period and assess the year-over-year trend.
• Earnings quality: Net income of $36.4 million versus operating income of $69.2 million implies a meaningful gap between operating and net earnings, which warrants examination of below-the-line items such as interest expense, tax rate, or non-recurring charges.
• Forward guidance: In selloffs of this magnitude, management's forward commentary in the earnings release or accompanying conference call typically drives the next leg of price action. Investors should focus closely on any updated full-year or Q4 outlook provided by the company.

The broader context for Novanta — a company serving robotics, medical, and advanced industrial end markets — means that any demand signals from these sectors embedded in the filing or guidance will be closely watched by the market.

---

Disclaimer

This report is a news and informational analysis based solely on data extracted from Novanta Inc.'s SEC filing and publicly available market data. It does not constitute investment advice, and no Buy, Hold, or Sell rating or price target is issued herein. Investors should conduct their own due diligence and consult a qualified financial adviser before making any investment decisions.

Existing Coverage

StockWatch has full coverage on NOVT, published 2026-09-22. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-09. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1076930/000119312526453802/novt-20261002.htm